Jastreboff AM, Aronne LJ, Ahmad NN, SURMOUNT-1 Investigators, et al
Related GLP-1 agonists like liraglutide showed benefits in case reports for compulsive food behaviors in neurodevelopmental disorders, but applicability to core OCD remains unproven
Retatrutide (LY3437943) is a synthetic 39-amino acid triple-hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously, commonly referenced in scientific literature for metabolic research, obesity mechanism studies, hepatic steatosis models, and energy expenditure pathway investigations in laboratory and preclinical environments
If you take Ozempic, there may be rare side effects like ischemic optic neuropathy